Home » Topics » Regulatory

Regulatory
RSS

FDA approves Opsumit for PAH

Oct. 21, 2013

FDA approves Novoeight for use in adults and children with hemophilia A

Oct. 17, 2013

Duavee approved for vasomotor symptoms and preventing postmenopausal osteoporosis

Oct. 4, 2013

Jublia approved in Canada for the treatment of onychomycosis

Oct. 4, 2013

FDA grants accelerated approval of new indication for Perjeta

Oct. 2, 2013

FDA approves vortioxetine for major depressive disorder

Oct. 1, 2013

FDA approves Cimzia for treatment of active psoriatic arthritis

Oct. 1, 2013

Simeprevir obtains first approval in Japan

Sep. 27, 2013

First approval in Europe for Gilead Sciences' cobicistat

Sep. 26, 2013

Bayer receives Canadian approval for riociguat in thromboembolic pulmonary hypertension

Sep. 26, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...